Autobio Diagnostics Co Ltd. Stock Analysis 603658.SS

Autobio Diagnostics Co., Ltd. engages in the research, development, production and sales of in vitro diagnostic reagents and instruments. The company is headquartered in Zhengzhou, Henan and currently employs 5,700 full-time employees. The company went IPO on 2016-09-01. The firm's main products include immunoassay reagents, microbiological detection reagents, molecular diagnostic detection reagents, biochemical detection reagents, immunoassay instruments, microbiological detection instruments, molecular detection instruments, mass spectrometry detection instruments, auxiliary testing instruments and other products. The firm conducts its business in the domestic and overseas markets.